Venture Capital

What can Milwaukee and Madison have to gain by collaborating? Plenty, according to Milwaukee Mayor Tom Barrett, who appeared with Madison Mayor Dave Cieslewicz in a forum of the Wisconsin Innovation Network. In an interview with WTN Media, Barrett outlined his vision for the M2...

After filing its annual and quarterly reports, Merge Healthcare has received word that it will continue to be listed on the NASDAQ Stock Market. The medical software developer had earlier announced that improper financial reporting was due in part to the bypassing of internal accounting...

With China's pharmaceutical and biotech industries still in their formative stages, their American, European, and Japanese counterparts should make significant investments in both India and China. Why? To take advantage of a talented labor pool and create markets for their own products, according to columnist...

The hottest new web programming tool, Ruby on Rails, is threatening to take market share from Sun Microsystem's Java and Microsoft's .Net. In this look at Ruby, Madison Area Technical College professor Eric Knapp gives the platform his benediction. ...

Madison has landed another maker of bioscience tools as part of a $5.85 million venture capital deal. Caden Biosciences will occupy 2,700 square feet in the Fitchburg Technology Campus, and have access to a community rich with life science workers. ...

Wisconsin companies that are preparing to compete for private equity capital will have an opportunity to learn more about the venture capital game this fall during the second annual Wisconsin Early Stage Symposium. The event was developed from the former Wisconsin Life Sciences & Venture...

Following an audit that called for better oversight of economic development programs, including certified capital companies, the founder of a leading venture capital firm disputes the findings. ...

Genzyme Corp., the Boston-based biotechnology firm that purchased Bone Care International in 2005, is suing three former employees of Bone Care and their new company, Cytochroma, alleging the theft of BCI's trade secrets in the development of new products. The employees, which include former Bone...